Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,045 | 53 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Veloxis Pharmaceuticals, Inc. | $366.87 | 8 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $334.52 | 22 | $0 (2023) |
| Gilead Sciences, Inc. | $209.06 | 15 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $62.28 | 3 | $0 (2023) |
| INTERCEPT PHARMACEUTICALS, INC. | $42.81 | 3 | $0 (2023) |
| Abbott Laboratories | $15.25 | 1 | $0 (2023) |
| Medtronic, Inc. | $13.85 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $33.09 | 1 | Veloxis Pharmaceuticals, Inc. ($33.09) |
| 2023 | $279.16 | 15 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($96.48) |
| 2022 | $521.43 | 23 | Veloxis Pharmaceuticals, Inc. ($234.68) |
| 2021 | $167.66 | 11 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($59.70) |
| 2020 | $43.30 | 3 | Gilead Sciences, Inc. ($28.92) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/17/2024 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $33.09 | General |
| Category: TRANSPLANTATION | ||||||
| 10/17/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: Rare Disease | ||||||
| 08/23/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Gastroenterology | ||||||
| 08/09/2023 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $29.85 | General |
| Category: TRANSPLANTATION | ||||||
| 06/07/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Gastroenterology | ||||||
| 05/16/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Gastroenterology | ||||||
| 04/24/2023 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Diabetes Care | ||||||
| 03/29/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Gastroenterology | ||||||
| 03/28/2023 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: TRANSPLANTATION | ||||||
| 03/10/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.62 | General |
| 03/03/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 02/21/2023 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: TRANSPLANTATION | ||||||
| 02/15/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Gastroenterology | ||||||
| 02/10/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.57 | General |
| 02/01/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Gastroenterology | ||||||
| 01/10/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Rare Disease | ||||||
| 12/02/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.00 | General |
| 11/09/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Gastroenterology | ||||||
| 11/09/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Gastroenterology | ||||||
| 11/07/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.21 | General |
| 10/20/2022 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | In-kind items and services | $102.85 | General |
| Category: Immunosuppresant | ||||||
| 10/20/2022 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | In-kind items and services | $102.85 | General |
| Category: Immunosuppresant | ||||||
| 10/19/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: Gastroenterology | ||||||
| 10/07/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.58 | General |
| 09/15/2022 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: Immunosuppresant | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 43 | 54 | $150,872 | $14,143 |
| 2022 | 3 | 76 | 81 | $293,194 | $26,650 |
| 2021 | 4 | 85 | 120 | $218,572 | $21,231 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 50360 | Transplantation of donor kidney | Facility | 2023 | 16 | 17 | $143,617 | $12,265 | 8.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 13 | 23 | $4,395 | $1,540 | 35.0% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2023 | 14 | 14 | $2,860 | $338.23 | 11.8% |
| 50360 | Transplantation of donor kidney | Facility | 2022 | 29 | 29 | $283,400 | $24,204 | 8.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 20 | 25 | $4,520 | $1,768 | 39.1% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2022 | 27 | 27 | $5,274 | $677.76 | 12.9% |
| 50360 | Transplantation of donor kidney | Facility | 2021 | 22 | 22 | $208,000 | $17,363 | 8.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 29 | 53 | $5,247 | $2,652 | 50.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 13 | 23 | $1,127 | $610.72 | 54.2% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2021 | 21 | 22 | $4,198 | $604.46 | 14.4% |
About Nitin Abrol
Nitin Abrol is a Surgery healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2017. The National Provider Identifier (NPI) number assigned to this provider is 1134647183.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nitin Abrol has received a total of $1,045 in payments from pharmaceutical and medical device companies, with $33.09 received in 2024. These payments were reported across 53 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($1,045).
As a Medicare-enrolled provider, Abrol has provided services to 204 Medicare beneficiaries, totaling 255 services with total Medicare billing of $62,023. Data is available for 3 years (2021–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Surgery
- Other Specialties Transplant Surgery
- Location Oklahoma City, OK
- Active Since 08/30/2017
- Last Updated 09/24/2020
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1134647183
Products in Payments
- XIFAXAN (Drug) $320.14
- Envarsus (Drug) $261.28
- ENVARSUS (Drug) $105.59
- ULTOMIRIS (Biological) $46.20
- OCALIVA (Drug) $42.81
- Ultomiris (Drug) $16.08
- FREESTYLE LIBRE (Device) $15.25
- PLENVU (Drug) $14.38
- SIGNIA (Device) $13.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in Oklahoma City
Jim Melton, D.o, D.O
Surgery — Payments: $215,212
Dr. William Mustain, M.d, M.D
Surgery — Payments: $126,114
Dr. Lenny Stubbs, M.d, M.D
Surgery — Payments: $70,884
Alexander Raines, Md, MD
Surgery — Payments: $51,895
Charles Elkins, Md, MD
Surgery — Payments: $48,908
Joshua Gierman, M.d, M.D
Surgery — Payments: $44,724